Influence of symmetrical and asymmetrical high flow cannulas on PCO2 reduction in hypercapnic COPD patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00035846

Enrollment

Registered

2025-05-27

Start date

2025-05-15

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J44

Interventions

Group 1: -Screening of patients with respiratory insufficiency type 2 and high flow therapy -Verification of inclusion/exclusion criteria -Signing of informed agreement and patient information -30 mi

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with known COPD and respiratory insufficiency type 2 (hypercapnic) - Compliance with drug therapy according to guidelines - Consent to the privacy policy and patient information - Cognitive and linguistic ability to answer the questionnaires

Exclusion criteria

Exclusion criteria: - Patient age less than 18 years - Not capable of giving consent

Design outcomes

Primary

Measure	Time frame
Comparison of the PCO2 results of the blood gas analyses and the transcutaneous CO2 measurement under symmetrical and asymmetrical high flow therapy after 30 minutes of therapy	—

Secondary

Measure	Time frame
1. Recording of data on wearing comfort 2. Recording of dyspnea data with BORG	—

Countries

Germany

Contacts

Public ContactSarah Bettina Stanzel

Lungenklinik Merheim, Kliniken der Stadt Köln gGmbH

Sarah.Stanzel@uni-wh.de0221 890718929

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026